Precise Biometrics AB (PREC)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 0.483 |
|---|---|
| 52-week range | 0.456 – 2.628 |
| Return, 1 month / 3 months | −14.0% / −54.0% |
| Return, 1 year / 3 years | −79.5% / −44.2% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 87.1% |
| Worst drawdown (1 year) | -81.4% |
| Average daily value traded | 0.93M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Precise Biometrics is a Swedish technology company based in Lund that develops fingerprint recognition software and algorithms. Its products match fingerprints captured by sensors and are licensed to makers of sensors, smartphones, smart cards and other devices, as well as used in identity and access applications. Customers are hardware and system suppliers that embed the software in their own products, and the company also offers related testing and evaluation tools for biometric systems.
Precise Biometrics AB trades under the code PREC on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Precise Biometrics AB (PREC) trades on the Stockholm Exchange in Sweden. It last closed at SEK 0.483 on 20 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 841 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 79.5% and over the last three months it fell 54.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 4 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -63.0% | ||
| From 52-week high | -80.7% | ||
| Momentum | 4 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -54.0% | ||
| 6-month return | -65.8% | ||
| 12-month return, skipping the last month | -76.1% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 87.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -81.4% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.93M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | −14.0% |
| 3 months | −54.0% |
| 6 months | −65.8% |
| 1 year | −79.5% |
| 3 years | −44.2% |
| 5 years | −93.7% |
Signals
| 50-day / 200-day average | 0.613 / 1.304 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.023 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.